Article ID Journal Published Year Pages File Type
2823783 Multiple Sclerosis and Related Disorders 2016 4 Pages PDF
Abstract
We provide evidence that supports the validity of GLTEQ scores as measures of vigorous and MVPA in POMS. Researchers and clinicians might adopt this scale for measuring PA.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Genetics
Authors
, , , ,